CAPS Company Profile and Key Details

Capstone Holding Corp. generated EPS of -$8.15 over the past year. Five-year average earnings growth is 1.77%. Capstone Holding Corp. earnings surprise history is a mixed track record. The quarter that ended November 18, 2025, missed forecasts by -391.67%. The prior quarter beat by 85.71%. Over the last six quarters, Apple has recorded several small beats. These include -57.27% in May 15, 2025.

CAPS has shown mixed momentum, gaining 13.06% over the past week and -27.28% over the past quarter, though year-to-date performance is up 1.9%. Short-term trend indicators are bullishly aligned (SMA20 12.79%, SMA50 0.8%, SMA200 -43.54%). The stock’s 14-day RSI is 54.63 (neutral), while the ATR of 0.06 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -83.97% below its high and over 36.76% above its low. Average 10-day trading volume of 21.34 million shares is significantly above the 3-month average of 2.04 million, indicating heightened recent market interest.

Capstone Holding Corp. has 5.58 million shares outstanding. The public float is 2.11 million shares, elevated short interest at 2.30% of float. This equals 45.56 thousand shares. The short ratio is 0.41 days. Institutional investors hold 0.83% of the float. Insiders own 62.18%.

Capstone Holding Corp. (NASDAQ:CAPS) closed at $0.39 USD, losing -$0.02 (-4.14%) from the previous close of $0.40. The stock is currently within 5% of its 52-week low $0.38 and $3.29. With a market capitalization of about $2.09 million, Capstone Holding Corp. is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.27). Key stats such as the average daily volume over the past year has been around 1.97 million shares, volume is running light vs its 52-week average. Headquartered in Alsip, IL, Capstone Holding Corp. operates in the Basic Materials sector and the Construction Materials industry. Led by CEO Matthew E. Lipman, the company employs approximately 36 people and listed since January 28, 1993. Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States.

Capstone Holding Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.74. This means the shares are trading below this model’s fair value.

Capstone Holding Corp. trades at a P/E ratio of -0.1, slightly below the S&P 500 average, with a price-to-sales ratio of 0.05 and a price-to-book ratio of 0.17 suggesting the stock is closer to book value. The P/FCF stands at -0.48, also above market averages.

Our AI price prediction model suggests that Capstone Holding Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -10.85%, with price expected at $0.36 by May 01, 2026, within a range of $0.30 to $0.42 3-Month Outlook: Projected fall of -92.57%, reaching $0.03 by July 16, 2026, with a range of $0.00 to $0.06. 1-Year Outlook: Projected loss of -23.23%, with price at $0.31 by April 16, 2027, within a range of $0.28 to $0.33.

Capstone Holding Corp. (NASDAQ:CAPS) shares are flat 1.9% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Capstone Holding Corp. trading at a premium to the broader market with a P/E of -0.1. Our AI forecast model points to short-term weakness (-10.85% over two weeks), a medium-term fall (-92.57% over three months), and a longer-term loss (-23.23% over one year), with expected trading ranges indicating moderate volatility.